We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

047810:KRXKorea Aerospace Industries, Ltd. Analysis

Data as of 2026-03-14 - not real-time

₩182,700.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Korea Aerospace Industries is trading above its short‑term, mid‑term and long‑term moving averages, indicating a bullish price trajectory, while the relative strength index sits in a neutral zone and trading volume has been on the rise. The MACD, however, has turned bearish, suggesting that the recent up‑move may be losing momentum and that a pull‑back toward the established support level could be imminent. Market sentiment is currently in a “greed” phase, which supports the bullish bias, but the upside potential is constrained by a clear resistance ceiling.
Fundamentally, the company is facing a steep revenue decline and thin profitability margins, compounded by a very high debt load and negative operating and free cash‑flow generation. The dividend yield is modest and the payout ratio, while not excessive, rests on fragile earnings, raising questions about long‑term sustainability. Valuation metrics sit above industry averages, and analyst price targets sit below the current market price, signaling that the stock may be overvalued relative to peers. Overall, the blend of technical softness and strained fundamentals suggests caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD divergence indicating near‑term weakness
  • Strong technical support but approaching resistance
  • Market sentiment skewed toward optimism

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue contraction and thin margins
  • High leverage and negative cash flow
  • Analyst price targets below current levels

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained debt burden and cash‑flow deficits
  • Questionable dividend sustainability
  • Valuation premium relative to industry peers

Key Metrics & Analysis

Financial Health

Revenue Growth-22.60%
Profit Margin4.12%
P/E Ratio34.7
ROE7.70%
ROA1.67%
Debt/Equity111.61
Op. Cash Flow₩-951170629632
Free Cash Flow₩-1202550079488
Industry P/E29.1

Technical Analysis

TrendBullish
RSI56.1
Support₩156,600.00
Resistance₩215,500.00
MA 20₩177,040.00
MA 50₩162,282.00
MA 200₩113,943.00
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price₩167,043.48
Upside/Downside-8.57%
GradeOvervalued
TypeValue
Dividend Yield0.27%

Risk Assessment

Beta0.04
Volatility87.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.